| Name | Title | Contact Details |
|---|
Seed to Skin Tuscany goes beyond the trend of purely natural skincare, combining the power of natures curative properties with the results-driven efficiency of advanced science. Five years ago, our founder and naturalist, Jeanette Thottrup, set out on a path to create truly effective skincare with nature at heart. Combining her expertise with the scientific know-how of leading cosmetologist, Dr. Anna Buonocore, she developed a line of products based on a targeted molecular delivery system we call green molecular science. Using cutting-edge technology, we extract the most active ingredients from potent botanicals and then rigorously select the right-sized molecules to penetrate the deepest layers of the skin. Clinically proven to work below the surface, our formulas go exactly where theyre needed to fully regenerate and hydrate the skin from the inside out. Our Conscious Beauty promise means we only use ethically sourced organic ingredients grown on our estate in Tuscany, or wild-foraged from land and sea by sustainable micro-farmers. Plus, all of our products are developed, produced and packaged onsite in our Seed to Skin laboratory, guaranteeing unparalleled quality control and traceability. The new benchmark in skincare, Seed to Skin works deep down to rejuvenate the skin with visible results: supple, plumped, ultra-moisturised skin that radiates from within.
Richard Cohen Landscape is a Lake Forest, CA-based company in the Business Services sector.
Dimensions In Glass is a Loveland, CO-based company in the Business Services sector.
Caris Life Sciences® (Caris) is the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched platform to deliver the next-generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection and drug development. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia and other international markets.